GLP-1 Medications and Medicare/Medicaid

Mark Ziats
Apr 5
1 min read

Updated: Oct 25

It appears for now anyway Ozempic / Wegovy / Zepbound / Monjuro will not be covered by medicare:

Medicare and Medicaid won’t pay for popular obesity drugs like Wegovy and Zepbound, rejecting, at least for now, a Biden administration proposal that would have expanded coverage for weight loss

https://www.wsj.com/health/healthcare/trump-administration-rejects-expanding-medicare-medicaid-coverage-of-obesity-drugs-f32ced38?st=pZanPk&reflink=article_gmail_share

Recent Posts

See All

Early TAVR for asymptomatic aortic stenosis

There have been many ongoing trials on this topic and they are finally starting to conclude that intervening early, even when the patient is asymptomatic, is beneficial once echocardiogram shows the p

Vaginal Estrogen and Stroke Risk

We get a lot of questions from women who would benefit from vaginal/topical estrogen but are appropriately concerned about increased risk for heart attack and stroke with estrogen supplementation. A n

Insomnia in Primary Care

Comments